Consensus DermTech, Inc.

Equities

DMTK

US24984K1051

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.6031 ^USD	+3.02%		-6.35%	-65.54%

Apr. 22	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 19	Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	MT

Evolution of the average Target Price on DermTech, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ee919d01e0.SZpq-_Co6maObTV0DnFeRStoTVSUapRmD-c4zIy1rpE.e_Aiq5rKvgz6O2QaVDtpMh9YNz_4J7kBQoR-o8PS2f0urjnWw8uDIfkbcA~63823dff6d51f6132c7ceef40fd5656c

Analyst Recommendations on DermTech, Inc.

Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	Apr. 19	MT
BTIG Downgrades DermTech to Neutral From Buy	Apr. 19	MT
BTIG Adjusts DermTech's Price Target to $2 From $4, Maintains Buy Rating	Mar. 07	MT
Stephens Trims Price Target on DermTech to $1.50 From $2.50, Keeps Equalweight Rating	Mar. 05	MT
BTIG Adjusts Price Target on DermTech to $5 From $6, Maintains Buy Rating	23-08-07	MT
Stephens Adjusts Price Target on DermTech to $5 From $16, Maintains Overweight Rating	22-11-09	MT
BTIG Adjusts Price Target on DermTech to $6 From $15, Maintains Buy Rating	22-11-08	MT
William Blair Downgrades DermTech to Market Perform From Outperform	22-11-04	MT
Oppenheimer Adjusts DermTech Price Target to $13 From $23, Maintains Outperform Rating	22-11-04	MT
Oppenheimer Adjusts DermTech's Price Target to $23 From $48, Maintains Outperform Rating	22-08-17	MT
BTIG Adjusts DermTech's Price Target to $15 From $19, Reiterates Buy Rating	22-08-15	MT
Craig-Hallum Adjusts DermTech's Price Target to $18 from $37, Maintains Buy Rating	22-08-09	MT
Oppenheimer Adjusts DermTech Price Target to $48 From $58, Maintains Outperform Rating	22-03-02	MT
Stephens Initiates DermTech With Overweight Rating, $26 Price Target	22-01-07	MT
Stephens Starts DermTech at Overweight	22-01-07	MT
BTIG Adjusts DermTech's Price Target to $48 From $53, Reiterates Buy Rating	21-11-22	MT
DERMTECH : BTIG Initiates DermTech at Buy With $53 Price Target	21-05-03	MT
DERMTECH : Oppenheimer Adjusts DermTech PT to $58 From $53 Following In Line Q4 Results, Maintains Outperform	21-03-05	MT
DERMTECH : Craig Hallum Adjusts DermTech PT to $70 From $49, Maintains Buy Rating	21-03-05	MT
DERMTECH : Oppenheimer Starts DermTech at Outperform With $53 Price Target	21-01-22	MT